Table 2 Characteristics of the included studies
Reference | Aim of study | No. of all publications included | Meta-Analysis | Time Horizon covered | Quality assessment tool | Screening or treatment |
|---|---|---|---|---|---|---|
Clegg, Scott et al. 2001 [84] | Examines the cost-effectiveness of four of the newer drugs –vinorelbine, gemcitabine, paclitaxel and docetaxel used for treating the most common type of lung cancer (non-small-cell lung cancer). | 16 | NO | 1995–2000 | appended appraisal questions | treatment |
Lange, Prenzler et al. 2014 [85] | review and assess the economic evidence of treatments with targeted agents in advanced: Non-small cell lung cancer | 19 | NO | 2000–2013 | The Quality of Health Economic Studies (QHES) | treatment |
Bongers, Coupe et al. 2012 [86] | comparing the new agents docetaxel, paclitaxel, vinorelbine, gemcitabine and pemetrexed, and the targeted therapies erlotinib and gefitinib with one another | 10 | NO | 2001–2010 | British Medical Journal (BMJ) 35-item checklist | treatment |
Raymakers, Mayo et al. 2016 [87] | cost-effectiveness of lung cancer screening using low-dose computed tomography (LDCT) | 13 | NO | 2000–2014 | Drummond checklist | Screening |
Maher, Miake-Lye et al. 2012 [88] | cost and cost-effectiveness of the different approaches in Treatment of Metastatic Non-Small Cell Lung Cancer | 22 | NO | 1996–2010 | - | treatment |
Brown, Pilkington et al. 2013[89] | Cost-effectiveness of first-line chemotherapy for patients with advanced and/or metastatic NSCLC. | 6 | NO | 1980–2010 | 35-item list described by Drummond and Jefferson | treatment |
Cao, Rodrigues et al. 2012[90] | describing cost-effectiveness of positron-emission tomography(PET) in staging of non–small-cell lung cancer (NSCLC) and management of solitary pulmonary nodules (SPN) | 18 | NO | 1950–2010 | Quality of Health Economic Studies (QHES) | Screening |
Black, Bagust et al. 2006 [58] | examine the cost-effectiveness of screening for lung cancer using computed tomography (CT) | 6 | NO | 1994–2005 | checklist developed by Drummond and colleagues | Screening |